The Antelope Valley Times

Your community. Your issues. Your news.

  • Home
  • Latest News
  • Local
    • Palmdale
    • Lancaster
    • Los Angeles County
    • Littlerock
    • Lake Los Angeles
    • Rosamond
    • Edwards AFB
    • Acton
  • Crime
  • Politics
  • Education
  • Health
  • Business
  • Opinion
    • Advertise
    • About
    • Contact Us
    • Facebook
    • Twitter
    Show Search

Study: Chemotherapy drug may be transformed into drug that kills cancer cells

by The AV Times Staff • December 7, 2020 Leave a Comment

[File]
LOS ANGELES – A study released Monday by investigators from Cedars-Sinai Medical Center shows the potential of transforming a commonly used chemotherapy drug into one that kills cancer cells by activating immune cells when it is paired with an anti-inflammatory medication.

Researchers said they discovered that the chemotherapy drug gemcitabine converted from a non-immunogenic drug — which is not able to activate a patient’s own immune response — to an immunogenic drug that triggered the immune response in mice when the anti-inflammatory medicine celecoxib (Celebrex) was added.

The combination of the two drugs delivered a “one-two punch” of killing tumor cells and activating immune cells, said Keith Syson Chan, a Cedars-Sinai translational scientist and the study’s corresponding author.

“I believe that our study has significant clinical potential, as cancer immunotherapy continues to emerge as an important pillar for treating cancer patients,” Chan said. “This discovery, if confirmed in clinical trials, may potentially increase the percentage of patients who respond to cancer immunotherapy.”

About 70% to 85% of patients currently taking immunotherapy drugs fail to respond to them, according to Chan.

Chan and the study’s first author, Kazukuni Hayashi, said they believe the immune response will perform even better if an immunotherapy drug is added to a gemcitabine and celecoxib treatment regimen, with a study underway in Chan’s laboratory to test that hypothesis.

“Harnessing the patients’ immune system to attack patients’ tumor cells has become an important tool for physicians treating cancer,” said Dr. Dan Theodorescu, director of the Cedars-Sinai Cancer enterprise. “Unfortunately, our current efforts fail in a significant number of patients. This study unveils at least one potential mechanism explaining these failures, and more importantly, provides a potential solution.”

The findings, made in human and mouse cancer cells and laboratory mice, were published in the peer-reviewed journal Nature Communications.

–

Filed Under: Health, Home, Los Angeles County

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Comments

  • Tim Klien on USC study: Telehealth, remote work could reduce vehicle trips after pandemic: “Breaking news! Using your vehicle less results in less vehicle less! What is wrong with these liberal snowflake universties?” Apr 20, 20:43
  • Tim Klien on Littlerock woman killed, Palmdale woman injured in rollover crash on Big Pines Highway: “Racist comments not welcome here Car accidents know no race!!!!” Apr 20, 20:40
  • Yani Pao on Littlerock woman killed, Palmdale woman injured in rollover crash on Big Pines Highway: “You will be missed Nub RIP” Apr 20, 20:29
  • Kree on L.A. County unveils $36.2 billion budget, emphasizes equity: “Pull ur pants down ladies n gentleman…..we are about to take it where the sun don’t shine…n very very deeeeeep” Apr 20, 16:59
  • Engineer Bill on Littlerock woman killed, Palmdale woman injured in rollover crash on Big Pines Highway: “More people die from auto accidents in the AV than homicides and Covid combined .” Apr 20, 16:47

© 2021 · The Antelope Valley Times. All rights reserved. Terms of Use